COVID 19 test
-
David Regan of Sona Nanotech on bringing their rapid saliva Covid-19 test to the market
In a recent InvestorIntel interview, Tracy Weslosky spoke with David Regan, CEO of Sona Nanotech Inc. (CSE: SONA | OTCQB:…
-
eResearch’s Chris Thompson with James Howard-Tripp on StageZero’s COVID-19 testing revenue
In a recent InvestorIntel interview, Chris Thompson speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
James Howard-Tripp on StageZero’s Q1 Results, Aristotle as part of the AVRT Program and the Rexall Partnership for COVID-19 Saliva Tests
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX:…
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
-
XPhyto Therapeutics Hugh Rogers on the fastest and most portable PCR test available
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp.…
-
Sixth Wave’s Dr Jon Gluckman on the competitive advantages of Molecular Imprint Polymers for the rapid detection of viruses
In a recent InvestorIntel interview, Tracy Weslosky speaks with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
Dr Gluckman on the rapid-detection benefits of Sixth Wave’s virus test kits
“You can think about our polymer almost like an antibody inside a body,” says Dr. Jonathan Gluckman, President,…